Autonomix Medical
AMIX
5 hedge funds and large institutions have $100K invested in Autonomix Medical in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$81.4K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$19.9K |
| 3 |
BlackRock
New York
|
+$18.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.64K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.32K |
Top Sellers
AMIX Hedge Fund Activity: Q1 2024 in Review
5 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Autonomix Medical (AMIX) for Q1 2024, worth a combined $100K.
Buyers outnumbered sellers: 5 funds opened new AMIX positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $81.4K.
- 5 institutional investors held Autonomix Medical (AMIX) as of Q1 2024, up from 0 in Q4 2023.
- Funds reported $100K of Autonomix Medical stock for Q1 2024.
- 5 funds opened new Autonomix Medical positions in Q1 2024 and 0 closed out, a net change of +5 holders.
- The largest Autonomix Medical buyer in Q1 2024 was Geode Capital Management, an estimated $81.4K added.
Based on aggregated 13F filings for Q1 2024.